A detailed history of Canal Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Canal Capital Management, LLC holds 22,965 shares of AMGN stock, worth $7.85 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares
22,965
Previous 22,352 2.74%
Holding current value
$7.85 Million
Previous $6.31 Million 24.42%
% of portfolio
1.2%
Previous 0.99%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 06, 2026

BUY
$290.13 - $341.71 $177,849 - $209,468
613 Added 2.74%
22,965 $7.85 Million
Q3 2025

Jan 06, 2026

BUY
$271.18 - $309.22 $196,334 - $223,875
724 Added 3.35%
22,352 $6.31 Million
Q2 2025

Sep 19, 2025

BUY
$262.28 - $309.85 $356,438 - $421,086
1,359 Added 6.7%
21,628 $6.04 Million
Q1 2025

Sep 19, 2025

BUY
$258.59 - $327.36 $5.24 Million - $6.64 Million
20,269 New
20,269 $6.31 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Canal Capital Management, LLC Portfolio

Follow Canal Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canal Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Canal Capital Management, LLC with notifications on news.